These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11365848)

  • 1. Report from the Seventh Immune Restoration Think Tank.
    Proj Inf Perspect; 1998 Sep; (25):23-4. PubMed ID: 11365848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.
    Beq S; Delfraissy JF; Theze J
    Eur Cytokine Netw; 2004; 15(4):279-89. PubMed ID: 15627636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F; Mezzaroma I
    AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune based therapies update.
    Proj Inf Perspect; 1997 Nov; (23):18-20. PubMed ID: 11365374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune-based therapies and HIV infection].
    Weiss L
    Ann Med Interne (Paris); 2002 Jun; 153(4):227-36. PubMed ID: 12218888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report from the Immune Restoration Think Tank.
    Lein B
    PI Perspect; 1996 Apr; (no 18):11-2. PubMed ID: 11363507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease.
    Kalayjian RC; Spritzler J; Pu M; Landay A; Pollard RB; Stocker V; Harthi LA; Gross BH; Francis IR; Fiscus SA; Tebas P; Bosch RJ; Valcour V; Lederman MM;
    J Infect Dis; 2005 Nov; 192(9):1577-87. PubMed ID: 16206072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report: immune restoration think tank.
    Lein B
    PI Perspect; 1995 May; (no 16):5-7. PubMed ID: 11362427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
    Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
    AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune restoration--conference outlines future directions.
    James JS
    AIDS Treat News; 1995 Mar; (no 218):3-4. PubMed ID: 11362327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
    Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
    J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune restoration think tank 5.
    Bowers M
    BETA; 1995 Dec; ():13, 53. PubMed ID: 11363004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
    Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
    Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection.
    Schmitt N; Nugeyre MT; Scott-Algara D; Cumont MC; Barré-Sinoussi F; Pancino G; Israël N
    AIDS; 2006 Feb; 20(4):533-42. PubMed ID: 16470117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.
    Marchetti G; Meroni L; Varchetta S; Terzieva V; Bandera A; Manganaro D; Molteni C; Trabattoni D; Fossati S; Clerici M; Galli M; Moroni M; Franzetti F; Gori A
    J Infect Dis; 2002 Sep; 186(5):606-16. PubMed ID: 12195347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune strategy.
    Proj Inf Perspect; 2004 Jan; (37):21-3. PubMed ID: 15119287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human growth hormone for thymus reconstitution.
    Proj Inf Perspect; 2003 Jan; (35):17. PubMed ID: 12647678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
    Benveniste O; Flahault A; Rollot F; Elbim C; Estaquier J; Pédron B; Duval X; Dereuddre-Bosquet N; Clayette P; Sterkers G; Simon A; Ameisen JC; Leport C
    J Infect Dis; 2005 May; 191(10):1670-9. PubMed ID: 15838794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human thymic dendritic cells: regulators of T cell development in health and HIV-1 infection.
    Evans VA; Cameron PU; Lewin SR
    Clin Immunol; 2008 Jan; 126(1):1-12. PubMed ID: 17916443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-based therapies in brief.
    Proj Inf Perspect; 2000 Mar; (29):19-20. PubMed ID: 12772669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.